InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,637.36
(
0.39%
)
US TECH 100
19,812.42
(
0.10%
)
Dow Jones
40,241.13
(
0.60%
)
Brent Oil
84.31
(
-0.34%
)
Bitcoin
63,541.15
(
4.54%
)
Post# of 30387
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Gold Seeker

Send PM Follow Ignore
Followers 29
Posts 9421
Boards Moderated 0
Alias Born 04/30/2006

Gold Seeker

Re: HALF FULL GLASS post# 18644

Saturday, 04/11/2009 12:25:47 PM

Saturday, April 11, 2009 12:25:47 PM

Post# of 30387
Half, your assumption that I agree with you is incorrect. The HaaH marker studies had 99% sensitivity and 93% specificity for lung cancer. If you want to start comparing studies verses studies then, I think the HAAH marker may have better numbers than RECAF. Why isn't it selling? Also, if you restrict this comparison to studies and not include clinical trials, the DR70 marker does well also.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up